Skip to main content

Table 2 Trends in national practice patterns of prostate cancer in Korea from 2005 to 2014

From: National practice patterns and direct medical costs for prostate cancer in Korea across a 10 year period: a nationwide population-based study using a national health insurance database

Characteristic 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Total (N) 3548 4313 5080 6225 6873 7262 8449 8825 8929 9092
Radical surgery
 RP 1102 (97.4) 1478 (94.4) 1812 (85.0) 1774 (61.8) 1933 (56.6) 1893 (52.5) 2416 (56.6) 2432 (55.7) 2478 (55.7) 2217 (50.9)
 RARP 29 (2.6) 88 (5.6) 320 (15.0) 1098 (38.2) 1480 (43.4) 1710 (47.5) 1850 (43.4) 1935 (44.3) 1973 (44.3) 2139 (49.1)
ADT
 Orchiectomy 174 (7.0) 117 (4.1) 90 (2.9) 79 (2.2) 67 (1.8) 41 (1.0) 38 (0.8) 32 (0.7) 21 (0.4) 28 (0.6)
 LHRH agonist only 769 (31.1) 887 (31.2) 1093 (34.8) 1155 (31.5) 1243 (32.6) 1231 (30.8) 1602 (35.6) 1655 (34.5) 1596 (33.6) 1740 (34.8)
 MAB 1322 (53.4) 1613 (56.7) 1791 (57.1) 2164 (58.9) 2228 (58.5) 2383 (59.6) 2531 (56.3) 2714 (56.6) 2760 (58.2) 2874 (57.5)
 Anti-androgen only 210 (8.5) 230 (8.1) 163 (5.2) 274 (7.5) 271 (7.1) 345 (8.6) 328 (7.3) 396 (8.3) 368 (7.8) 352 (7.0)
Primary treatment
 Surgery only 835 (23.5) 1153 (26.7) 1576 (31.0) 2187 (35.1) 2592 (37.7) 2738 (37.7) 3314 (39.2) 3478 (39.4) 3595 (40.3) 3585 (39.4)
 Surgery+ADT 74 (2.1) 124 (2.9) 186 (3.7) 297 (4.8) 336 (4.9) 334 (4.6) 387 (4.6) 360 (4.1) 350 (3.9) 368 (4.0)
 Surgery+RT 170 (4.8) 208 (4.8) 274 (5.4) 278 (4.5) 358 (5.2) 400 (5.5) 398 (4.7) 327 (3.7) 333 (3.7) 225 (2.5)
 Surgery+ADT + RT 52 (1.5) 81 (1.9) 96 (1.9) 110 (1.8) 127 (1.8) 131 (1.8) 167 (2.0) 202 (2.3) 173 (1.9) 178 (2.0)
 RT only 68 (1.9) 105 (2.4) 93 (1.8) 88 (1.4) 114 (1.7) 124 (1.7) 238 (2.8) 223 (2.5) 256 (2.9) 288 (3.2)
 ADT only 1831 (51.6) 2011 (46.6) 2216 (43.6) 2613 (42.0) 2745 (39.9) 2820 (38.8) 3044 (36.0) 3185 (36.1) 3271 (36.6) 3544 (39.0)
 ADT + RT 518 (14.6) 631 (14.6) 639 (12.6) 652 (10.5) 601 (8.7) 715 (9.8) 901 (10.7) 1050 (11.9) 951 (10.7) 904 (9.9)
  1. RP Radical prostatectomy, RARP Robotic-assisted laparoscopic radical prostatectomy, ADT Androgen deprivation therapy, LHRH Luteinizing hormone-releasing hormone, MAB Maximal androgen blockade, RT Radiotherapy